EFSA Journal (Mar 2024)

Assessment of the feed additive consisting of Enterococcus lactis NCIMB 10415 (Cylactin®) for cats and dogs for the renewal of its authorisation (DSM Nutritional Products Ltd.)

  • EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP),
  • Vasileios Bampidis,
  • Giovanna Azimonti,
  • Maria de Lourdes Bastos,
  • Henrik Christensen,
  • Mojca Durjava,
  • Birgit Dusemund,
  • Maryline Kouba,
  • Marta López‐Alonso,
  • Secundino López Puente,
  • Francesca Marcon,
  • Baltasar Mayo,
  • Alena Pechová,
  • Mariana Petkova,
  • Fernando Ramos,
  • Roberto Edoardo Villa,
  • Ruud Woutersen,
  • Paul Brantom,
  • Natalia Alija‐Novo,
  • Montserrat Anguita,
  • Rosella Brozzi,
  • Jaume Galobart,
  • Matteo Lorenzo Innocenti,
  • Fabiola Pizzo,
  • Joana Revez,
  • Nicole Bozzi Cionci

DOI
https://doi.org/10.2903/j.efsa.2024.8622
Journal volume & issue
Vol. 22, no. 3
pp. n/a – n/a

Abstract

Read online

Abstract Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the assessment of the application for renewal of the authorisation of Cylactin® as a zootechnical feed additive for cats and dogs. The active agent of the additive is Enterococcus lactis NCIMB 10415 and the micro‐encapsulated formulation, Cylactin® LBC ME5 PET, was assessed. The applicant has provided evidence that the additive currently on the market complies with the existing conditions of authorisation. The Panel concluded that the additive remains safe for cats and dogs. Regarding user safety, the additive was not shown to be skin and eye irritant, but it should be considered a respiratory sensitiser. No conclusions can be drawn on the skin sensitisation. There is no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.

Keywords